(44.222.64.76)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 8
First page : ( 3617) Last page : ( 3623)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00666.2

An Invasive Launch of Two Compendiums: Orange Book and Purple Book by FDA

Priya D. Vetri*, Kamaraj Raju

Department of Pharmaceutical Regulatory Affairs, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, 603203, Kanchipuram, Tamil Nadu, India

*Corresponding Author E-mail: vetripriya95@gmail.com

Online published on 31 October, 2018.

Abstract

This article particularly focuses on the Orange Book which is more formally known as the Approved Drug Products with Therapeutic Equivalence Evaluations and also on the Purple Book-more formally known as List of Licensed Biological Products with Exclusivity of Reference product and Biosimilarity or Interchangeability Evaluations. Major topics covered in this article include: the legislative background of the ‘Orange Book’, safety and effectiveness, Hatch-Waxman Act, Patents and exclusivity comparisons, (ANDA) Abbreviated New Drug Application Patent Certification process, Contents of the Orange Book, Therapeutic Equivalence Code, Electronic Orange Book and about the Upgrade of Orange Book. In addition to this it also reviews the FDA's Purple Book in detail. Since the use of biological products ha exponentially increased over the last few decades new regulations for reducing the cost of the original Biological Products have been framed among which the Purple Book was also one such stride. These types of reference guide will assist the pharmacists to provide leadership to the public about the substitution of appropriate generic and Biologic equivalents to the reference product. Hence let's plunge into the article for more interesting information.

Top

Keywords

Orange Book, Purple Book, Biological Products, Reference Product Exclusivity, Biosimilarity, Hatch-Waxman Act, Patent Certification, Therapeutic Equivalence Code, Electronic Orange Book.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
760,224,300 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.